866-997-4948(US-Canada Toll Free)

OTC PAIN MANAGEMENT - US - JULY 2019

Published By :

Mintel

Published Date : Jul 2019

Category :

Medical Equipments

No. of Pages : N/A

The OTC pain management market exceeded $6.5 billion in 2018. Historically, the category depends on the success of internal analgesics, yet the external segment continues to offer booming potential, maintaining impressive year-over-year growth. Demand for OTC pain relievers will continue as incidence of pain is not slated to slow down, but key players must acknowledge that people are becoming more connected with their bodies and overall health. As adults become more comfortable discussing mental health conditions, expect an increase of consumers associating pain with emotional stressors.

Table of contents
OVERVIEW
What you need to know
Definition
EXECUTIVE SUMMARY
Market Overview
Market performance
Figure 1: Total US sales and fan chart forecast of OTC pain management products, at current prices, 2014-24
Slowed growth of internal segment
Figure 2: Total US retail sales and percent sales change of internal analgesics, at current prices, 2014-24
The issues
Growing accessibility of CBD challenges OTC pain market
Figure 3: Reasons for using CBD-only products (no THC), February 2019
Familiarity with active ingredients bolsters private label, challenges brand names
Figure 4: OTC pain management purchasing factors, April 2019
The opportunities
Addressing mental health could bolster consumer trust
Figure 5: Pain association and frequency, April 2019
Consumers in more pain, need more relief
Figure 6: Reasons for taking oral OTC pain relievers more often, by product use, April 2019
What it means
THE MARKET – WHAT YOU NEED TO KNOW
OTC pain management market growth continues
Internals lead the category; externals show potential
Hot topics in pain relief: CBD and cannabis
Acknowledging period pain resonates with informed consumers
Opioid crisis retains status as a public health emergency
Stress and sleep deprivation lead to pain
MARKET SIZE AND FORECAST
OTC pain management market maintains steady growth
Figure 7: Total US sales and fan chart forecast of OTC pain management products, at current prices, 2014-24
Figure 8: Total US retail sales and forecast of OTC pain management products, at current prices, 2014-24
MARKET BREAKDOWN
Internal analgesics dominate market share; externals gain momentum
Figure 9: Total US retail sales and percent sales change of internal analgesics, at current prices, 2014-24
Figure 10: Total US retail sales and forecast of OTC pain management products, by segment, at current prices, 2014-24
On the decline: OTC pain relief purchases from other retailers
Figure 11: Total US retail sales of otc pain management products, by channel, at current prices, 2014-19
MARKET PERSPECTIVE
Hemp-derived CBD hits mainstream drug stores
Cannabis legalization gains traction
Figure 12: Reasons for using marijuana/cannabis (any format), February 2019
Cycling through the menstrual taboo
MARKET FACTORS
The push for alternative pain management in response to opioid crisis
Stressed out population experiences high incidence of pain
Figure 13: Pain association and frequency, by product use, April 2019
Sleep-deprived adults turn to OTC pain relievers
KEY PLAYERS – WHAT YOU NEED TO KNOW
J&J maintains grip on OTC pain market
Gender targeting sees success for pain relief products
Natural remedies establish presence in external segment
Low repurchase need and lack of innovation hinders segment performance
Accessibility of CBD could alter pain management market
Mental and physical health link changes the way consumers manage pain
COMPANY AND BRAND SALES OF OTC PAIN MANAGEMENT MARKET
J&J maintains market share; competitors fall behind
Figure 14: Multi-outlet sales of OTC pain management products, by leading companies, rolling 52 weeks 2018 and 2019
Internal analgesic sales stagnant; J&J sustains growth
Figure 15: Multi-outlet sales of internal analgesics, by leading companies and brands, rolling 52 weeks 2018 and 2019
Advil Liquid-Gels outperforms other Advil offerings
Figure 16: Multi-outlet sales of select internal analgesics, by Pfizer’s Advil offerings, rolling 52 weeks 2018 and 2019
WHAT’S WORKING?
Personalizing pain management for women
Supportive brand dialogue shatters stigma around period pain
Figure 17: Midol sponsored social media campaign
Figure 18: Multi-outlet sales of select internal analgesics, by Midol brand, rolling 52 weeks 2017, 2018 and 2019
Embracing gender distinctions: pain relief for menopause
Figure 19: Equelle Official Instagram post, menopause relief
Figure 20: The Good Patch Instagram post, period patch
Male demographic responds to aspirational marketing
Figure 21: Pain association and frequency, by males 18-34, April 2019
Natural remedies resonate in external segment
Figure 22: Multi-outlet sales of select external analgesics, by leading companies and brands, rolling 52 weeks 2018 and 2019
Pain personification
Figure 23: Instagram Post, celebrity endorsed Excedrin ad
Figure 24: Instagram Post, celebrity endorsed Excedrin post
Figure 25: Multi-outlet sales of select internal analgesics, by leading companies and brands, rolling 52 weeks 2018 and 2019
WHAT’S STRUGGLING?
High cost and low innovation inhibit consumer acceptance of OTC TENS devices
Figure 26: Multi-outlet sales of electrotherapy devices, by leading companies and brands, rolling 52 weeks 2018 and 2019
Growth stalls for muscle/body support devices
Figure 27: Multi-outlet sales of muscle and body support devices, by leading companies and brands, rolling 52 weeks 2018 and 2019
Recalls in children’s ibuprofen
Figure 28: Multi-outlet sales of select internal analgesics, by leading companies and brands, rolling 52 weeks 2018 and 2019
WHAT’S NEXT?
Plant-based pain relief: widespread availability of CBD products
Consumer recognition of mental wellness necessitates brand response
Figure 29: Holistic health approach, November 2018
Figure 30: Pain association and frequency of select factors, April 2019
Using shelf presence to turn heads in-store
Figure 31: Attitudes toward purchasing OTC pain relievers, April 2019
THE CONSUMER – WHAT YOU NEED TO KNOW
Consumers depend on OTC pain relievers
Active ingredients and previous experience matter at check out
Mental health is a leading factor of regularly experienced pain
More frequent pain impacts reliance on OTC pain relievers
Natural ingredients pique consumer interest
Travel-sized formats may resonate with consumers who always keep pain relievers on hand
PRODUCT USAGE
Consumers rely on oral OTC pain relievers to manage pain
Figure 32: Product use, April 2019
Men are motivated by externals; women stick to traditional pain relief
Figure 33: Product use, by gender and age, April 2019
Most consumers use one product to manage pain
Figure 34: Repertoire of product use, April 2019
Figure 35: Repertoire of product use, by product use, April 2019
OTC PAIN MANAGEMENT PURCHASING FACTORS
Familiarity drives purchases
Figure 36: OTC pain management purchasing factors, April 2019
Older consumers stick to what they know; young adults ask for more
Figure 37: OTC pain management purchasing factors, by age, April 2019
Ingredient awareness may shift pain relief methods
Figure 38: Changes in taking oral OTC pain relievers, by purchasing factors, April 2019
Young women value targeted pain relief
Figure 39: Select OTC pain management purchasing factors, by males and females 18-34, April 2019
Figure 40: Motrin Instagram post
Figure 41: Motrin Instagram page
PAIN ASSOCIATION AND FREQUENCY
Mental health factors outweigh physical
Figure 42: Pain association and frequency, April 2019
Younger demographic struggles with pain heightened by mental and emotional factors
Figure 43: Pain association and frequency, by age, April 2019
Topical relief for stress-induced pain
Figure 44: Pain association and frequency, by product use, April 2019
Parental pain caused on the job
Figure 45: Pain association and frequency, by marital status by parental status of children under 18, April 2019
CHANGES IN USAGE OF ORAL OTC PAIN RELIEVERS
More adults have increased use of oral OTC pain relievers
Figure 46: Changes in usage of oral OTC pain relievers, April 2019
More pain = more usage; an opportunity for the external segment
Figure 47: Reasons for taking oral OTC pain relievers more often, April 2019
Figure 48: Reasons for taking oral OTC pain relievers more often, by product use, April 2019
Stressed-out women increase use of oral pain relievers
Figure 49: Changes in usage of oral OTC pain relievers, by gender and age, April 2019
Figure 50: Taking oral OTC pain relievers more often due to stress, by gender and age, April 2019
Concern about long-term side effects challenges reliance on internal segment
Figure 51: Reasons for taking oral OTC pain relievers less often, April 2019
TRIAL AND INTEREST IN ALTERNATIVE PAIN RELIEF METHODS
High trial of medicated externals; high interest of natural methods
Figure 52: Trial and interest in alternative pain relief methods, April 2019
Use of natural products is motivated by overall health and feeling better
Figure 53: Select natural lifestyle motivators, April 2017
Young consumers are key demographic for natural pain relief
Figure 54: Trial and interest in alternative pain relief methods, April 2019
Figure 55: The Good Patch Instagram, CBD-infused pain patch
Young moms offer new target for muscle/body support devices
Figure 56: Interest in muscle/body support devices, by gender and parental status, April 2019
ATTITUDES TOWARD PURCHASING OTC PAIN RELIEVERS
In-store purchasing necessitates presence on shelf
Figure 57: Attitudes toward purchasing OTC pain relievers, April 2019
Consumers want to feel prepared at the onset of pain
Figure 58: Hot to Go Instagram Post, heat packs
Older adults establish routines to find mobility
Figure 59: Pain association and frequency of arthritis, by age, April 2019
Figure 60: Attitudes toward purchasing OTC pain relievers, by age, April 2019
APPENDIX – DATA SOURCES AND ABBREVIATIONS
Data sources
Sales data
Fan chart forecast
Consumer survey data
Abbreviations and terms
Abbreviations
APPENDIX – THE MARKET
Figure 61: Total US retail sales and forecast of otc pain management products, at inflation-adjusted prices, 2014-24
Figure 62: Total US retail sales of otc pain management products, by segment, at current prices, 2017 and 2019
Figure 63: Total US retail sales and forecast of internal analgesics, at current prices, 2014-24
Figure 64: Total US retail sales and forecast of muscle/body support devices, at current prices, 2014-24
Figure 65: Total US retail sales of otc pain management products, by channel, at current prices, 2017 and 2019
Figure 66: US supermarket sales of otc pain management products, at current prices, 2014-19
Figure 67: US sales of otc pain management products through other retail channels, at current prices, 2014-19
Figure 68: US sales of otc pain management products through other retail channels, at current prices, 2014-19
APPENDIX – KEY PLAYERS
Figure 69: Multi-outlet sales of external analgesics, by leading companies and brands, rolling 52 weeks 2017 and 2018

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *